External Review of Guidelines

BC Guidelines Logo

BC health care professionals and relevant stakeholders are invited to participate as external reviewers for the draft version of BC Guidelines. Peer review is a critical component of the guideline development process. New and existing guidelines that have undergone substantive changes are subject to external review to make sure they are clearly written, practical and free of errors.

Guidelines Currently in External Review:

 

Colorectal Cancer guideline: Open for External Review until February 16th, 2022

Part 1 of the guideline provides recommendations for the detection of colorectal cancer (CRC) and precancerous lesions in asymptomatic adults, including those with hereditary syndromes. Part 2 of the guideline provides follow up recommendations for patients after curative resection of CRC or colorectal precancerous lesions (previously referred to as polyps). These recommendations are intended to rationalize surveillance following removal of a lesion and to prevent the development of additional CRC. 

We appreciate your participation in the external review.

Step 1: Download the draft guideline for review (PDF):

Step 2: Complete the online questionnaire by February 16th, 2022 at:

Any additional comments on the guideline can be submitted by:

 

Infectious Diarrhea guideline: Open for External Review until February 23rd, 2022

This guideline provides guidance for primary care practitioners regarding adults and children greater than 2 months of age on appropriate testing for suspected community onset infectious diarrhea, including Clostridioides difficile infection. This guideline does not apply to outbreak situations, or patients with hospital onset diarrhea. The Infectious Diarrhea Panel (IDP) is a new stool test that combines stool cultures, ova & parasites (O&P) and C. difficile within a single specimen. It functionally replaces stool cultures and O&P, however standalone C. difficile tests are still available. This guideline serves to describe the most appropriate use of IDP, and the use and interpretation of C. difficile tests. The Infectious Diarrhea Panel (IDP) is not yet implemented in BC. Please do not order the test until the guideline is published and the laboratories have announced that the test is available.

Step 1: Download the draft guideline for review (PDF):

Step 2: Complete the online questionnaire by February 23rd, 2022 at:

Any additional comments on the guideline can be submitted by:

 

We depend on B.C. health care professionals to review our draft guidelines. Our external review involves 1) regular mail sent to a random sample of B.C. physicians and relevant specialists, and 2) emails to a group of key partners in areas such as pharmacy, laboratory procedures, health authorities, public health, and  professional colleges and associations. All feedback received is reviewed by the GPAC guideline working group. For more information on our external review process, please see the GPAC Handbook.

Earning Credit for Continuing Professional Development

Physicians who act as external reviewers for BC Guidelines may be eligible to receive credit towards continuing professional development or continuing medical education. For more information, see Continuing Professional Development (CPD) Credits.